Faith-based Approaches to Treating Hypertension and Colon Cancer Prevention
FAITH-CRC
2 other identifiers
interventional
451
1 country
1
Brief Summary
Primary Aim: To evaluate the effect of a lifestyle intervention delivered through telephone-based motivational interviewing (MINT) versus a patient navigation intervention on blood pressure reduction and CRC screening. Hypotheses: Among black men, aged \> 50 years with uncontrolled HTN and in need of CRC screening:
- 1.Hyp. 1: those randomized to the lifestyle intervention will have lower BP compared to those randomized to the patient navigation intervention at 6 months.
- 2.Hyp. 2: those randomized to the patient navigation intervention will have higher CRC screening rates compared to those randomized to the lifestyle intervention at 6 months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2011
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2011
CompletedFirst Submitted
Initial submission to the registry
July 27, 2011
CompletedFirst Posted
Study publicly available on registry
July 29, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2015
CompletedNovember 13, 2015
November 1, 2015
4.3 years
July 27, 2011
November 11, 2015
Conditions
Outcome Measures
Primary Outcomes (2)
Blood Pressure
The primary outcomes will be (1) within-patient change in systolic and diastolic BP from baseline to 6 months and (2) CRC screening rates as determined by colonoscopy report or fecal immunochemical test (FIT) result from the primary care provider at 6 months. Blood pressure will be assessed with an automated digital BP monitor based on American Heart Association guidelines.1 CRC screening will be assessed by self-report and verified with medical records and/or the actual colonoscopy or FIT report from participants' providers.
6-months
Colorectal Cancer Screening
The primary outcomes will be (1) within-patient change in systolic and diastolic BP from baseline to 6 months and (2) CRC screening rates as determined by colonoscopy report or fecal immunochemical test (FIT) result from the primary care provider at 6 months. Blood pressure will be assessed with an automated digital BP monitor based on American Heart Association guidelines.1 CRC screening will be assessed by self-report and verified with medical records and/or the actual colonoscopy or FIT report from participants' providers.
6M
Study Arms (3)
Motivational Interviewing
EXPERIMENTALThe use of a one-on-one motivational interviewing counseling intervention, 4 visits over 5 months, focusing on changes to behavior related to blood pressure control.
Patient Navigation
EXPERIMENTALThe use of a patient navigation intervention to guide participants through the process of getting screened for colorectal cancer.
PLUS
EXPERIMENTALThis group receives both the motivational interviewing intervention and the patient navigation intervention.
Interventions
One-on-one client-centered counseling for lifestyle changes related to blood pressure control
One-on-one navigation to guide participants through the process of being screened for colorectal cancer.
Eligibility Criteria
You may qualify if:
- Participants must be age 50 years or older
- Participants must have a working telephone (a necessary criterion since much of the interventions are telephone based)
- Self-identified as a black or African American and male
- Have uncontrolled hypertension defined as SBP\>135 mmHg or DBP\>85 mmHg and SBP \>130 mmHg or DBP \>80 mmHg (in those with diabetes) at the screening
- Have a need for CRC screening defined as: 1) no colonoscopy in the last 10 years; 2) no Flexible sigmoidoscopy, Digital Contrast Barium Enema or CT-colonoscopy in the last 5 years, or 3) no Fecal Immunochemical Test or Fecal Occult Blood Test in the last 12 months.
- All participants must be fluent in English. Certain measures used have not been verified in other languages.
You may not qualify if:
- Inability to comply with the study protocol (either self-selected or by indicating during screening that he could not complete all requested tasks).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
New York University School of Medicine
New York, New York, 10010, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Joseph Ravenell, MD, MS
NYU Langone Health
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 27, 2011
First Posted
July 29, 2011
Study Start
March 1, 2011
Primary Completion
June 1, 2015
Study Completion
June 1, 2015
Last Updated
November 13, 2015
Record last verified: 2015-11